We Power Adoption

of clinical AI, for healthcare companies, health systems and investors worldwide

The Other Side of the Table

Most healthcare consultancies help health systems buy technology well. HealthCursor works the other side of the table: we help clinical AI and digital health companies, and the investors behind them, sell, deploy and scale. Fifteen years of senior operating mandates, two companies later acquired, and nineteen countries of delivery taught us that in clinical AI the hard problem has moved from building the model to earning its adoption. That is the problem we work on, and the only one.

What we do

Who We Support

Clinical AI & Digital Health Companies

Commercial strategy, pricing, evidence-to-revenue mapping and market entry for companies whose technology works but whose revenue does not yet match it. From your first NHS contract to your nineteenth country.

Healthcare Investors

Commercial and impact due diligence that reads like an operator wrote it, and portfolio value creation that survives contact with the sales pipeline. For private equity, venture capital, corporate investors and development finance institutions, to GIIN-aligned standards.

Health Systems & Institutions

Independent, vendor-neutral advice on adoption, procurement readiness and scaling innovation, drawing on advisory work for the IFC World Bank, development finance and public health systems worldwide.

Global Healthcare Expertise

Fifteen years of delivery for payers, providers, life sciences companies and investors, from London to New Delhi, São Paulo to the Gulf.

250+consulting, operating and advisory assignments since 2010
19countries of delivery
15years of delivery worldwide

Combined record of firm engagements and principal operating mandates since 2010. Client names are not disclosed; references are available under NDA.

Why HealthCursor

We have carried the number, not just benchmarked it. Our commercial recommendations are formed inside real pipelines, through operating mandates at companies that went on to be acquired, so they survive contact with actual buyers.Operator judgement
One firm across borders. From a first NHS contract to the Gulf, India and Brazil, the same principal-led method, proven at programme scale with the IFC's TechEmerge.Global reach
Diligence that challenges the numbers. Our impact and commercial due diligence is built to GIIN-aligned standards and is willing to disagree with management when the evidence says so.Independent rigour

Our Latest Thinking

26

The Map Has Been Redrawn: Selling to the NHS After ICB Consolidation

Forty-two commissioners have become thirty-six, on the way to roughly twenty-six; legislation to fold NHS England into the department is before Parliament; and every vendor's account plan is now out of date. What to do about it.

Ai

The Model Was Never the Bottleneck

Why capability stopped being the constraint in clinical AI, and what replaced it: procurement, trust, workflow and the economics of adoption.

All Insights

Learn How We Can Help You

It won't take long. Give us a few minutes to describe your needs and we'll get back to you shortly.

Contact Us

London

Registered Office
14/2E Docklands Business Centre
10-16 Tiller Road, London E14 8PX

South Asia

Fifteen years of delivery in India,
including the IFC TechEmerge
programme from New Delhi

Middle East

Market entry and government
engagement across the Gulf
through a partner network

Americas

Programme experience across
the United States, Brazil
and multilateral institutions